IL17A and rheumatoid arthritis: The study went further to demonstrate that inflammatory cytokines such as interleukin 1 (IL-1), interleukin 17 (IL-17) and tumor necrosis factor alpha (TNF-α) expressed during rheumatoid arthritis leads to increases in myostatin expression which in turns enhances osteoclast differentiation6.